FRMD6 and glioblastoma: Our results show that increased expression of FRMD6 significantly inhibits the subcutaneous growth (Figure 3A, 3C) and intracranial progression (Figure 3B, 3D, Supplementary Figure S2) of GBMs and extends survival of experimental mice that were intracranially implanted with the GBM cells.